Air Liquide Adds Third US CO2 Liquefaction Plant

Air Liquide Industrial US LP has commissioned a new 450 t/d carbon dioxide liquefaction plant in Tulare County, California, bringing to three the number of carbon dioxide liquefaction facilities it owns and operates in the state.

The new state-of-the-art facility captures CO2 emissions from an ethanol plant owned by Calgren Renewable Fuels, then purifies and liquefies it to meet the specifications of the diverse food, beverage and manufacturing industries in the region.

Liquid carbon dioxide provides manufacturers the benefit of quickly freezing and preserving their products and also helps maintain safe temperatures that improve quality in certain manufacturing processes, the US subsidiary of the French gases producer explains.

Air Liquide owns and operates 11 other carbon dioxide liquefaction facilities in the US, all of which have received the Food Safety System Certification 22000 ("FSSC 22000"), an internationally recognized standard for food safety systems.

The plants are located in Delaware City, Delaware; Martinez, California; Sioux City, Iowa; Wood River, Illinois; Washington, Indiana; Wilmington, California; and, Donaldsonville, Louisiana.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.